<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Non-invasive cancer diagnostics &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/non-invasive-cancer-diagnostics/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 22 Oct 2025 20:42:26 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Non-invasive cancer diagnostics &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>New Genomic Test May Help Melanoma Patients Avoid Lymph Node Biopsy Surgery</title>
		<link>https://bioengineer.org/new-genomic-test-may-help-melanoma-patients-avoid-lymph-node-biopsy-surgery/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 22 Oct 2025 20:41:57 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[melanoma genomic test]]></category>
		<category><![CDATA[Merlin CP-GEP Test]]></category>
		<category><![CDATA[molecular biomarkers]]></category>
		<category><![CDATA[Non-invasive cancer diagnostics]]></category>
		<category><![CDATA[non-invasive cancer staging]]></category>
		<category><![CDATA[Precision Medicine in Oncology]]></category>
		<category><![CDATA[precision oncology diagnostics]]></category>
		<category><![CDATA[sentinel lymph node biopsy alternatives]]></category>
		<category><![CDATA[sentinel lymph node biopsy avoidance]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-genomic-test-may-help-melanoma-patients-avoid-lymph-node-biopsy-surgery/</guid>

					<description><![CDATA[In a groundbreaking advancement within oncology, researchers at Mayo Clinic, in collaboration with SkylineDx, have unveiled a novel genomic test that promises to revolutionize the management of melanoma by predicting the likelihood of cancer’s presence in the lymph nodes. Published in the prestigious journal JAMA Surgery, this test harnesses cutting-edge molecular diagnostics to guide therapeutic [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">285441</post-id>	</item>
		<item>
		<title>Plasma MicroRNA Patterns Reveal Cervical Cancer Insights</title>
		<link>https://bioengineer.org/plasma-microrna-patterns-reveal-cervical-cancer-insights/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 05 Sep 2025 05:21:02 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cervical cancer Ghana study]]></category>
		<category><![CDATA[gene expression regulation]]></category>
		<category><![CDATA[Non-invasive cancer diagnostics]]></category>
		<category><![CDATA[Oncological biomarkers research]]></category>
		<category><![CDATA[Plasma microRNA biomarkers]]></category>
		<guid isPermaLink="false">https://bioengineer.org/plasma-microrna-patterns-reveal-cervical-cancer-insights/</guid>

					<description><![CDATA[In a groundbreaking study, researchers revealed valuable insights into the expression patterns of plasma microRNAs in patients battling cervical cancer in Ghana. This research, led by a team including Quayson, Bonney, and Sam, casts light on a crucial yet understudied aspect of oncological biomarkers that could potentially enhance patient management and treatment outcomes. The findings [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">259029</post-id>	</item>
		<item>
		<title>Innovative Urine-Based Tumor DNA Test Promises Personalized Bladder Cancer Therapy</title>
		<link>https://bioengineer.org/innovative-urine-based-tumor-dna-test-promises-personalized-bladder-cancer-therapy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 27 Jun 2025 18:18:49 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[atezolizumab immunotherapy outcomes]]></category>
		<category><![CDATA[BCG-unresponsive NMIBC]]></category>
		<category><![CDATA[Non-invasive cancer diagnostics]]></category>
		<category><![CDATA[personalized bladder cancer therapy]]></category>
		<category><![CDATA[urine tumor DNA analysis]]></category>
		<guid isPermaLink="false">https://bioengineer.org/innovative-urine-based-tumor-dna-test-promises-personalized-bladder-cancer-therapy/</guid>

					<description><![CDATA[A groundbreaking multi-institutional study has unveiled a promising approach to improving the management of bladder cancer by utilizing urine-based tumor DNA (utDNA) analysis. Published in the prestigious journal European Urology, the research highlights how quantifying utDNA can predict the risk of recurrence in patients undergoing immunotherapy, specifically those treated with atezolizumab. This advance heralds a [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">250644</post-id>	</item>
		<item>
		<title>Revolutionizing Breast Cancer Treatment: The Role of Liquid Biopsy</title>
		<link>https://bioengineer.org/revolutionizing-breast-cancer-treatment-the-role-of-liquid-biopsy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 18 Feb 2025 18:15:06 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[circulating tumor DNA testing]]></category>
		<category><![CDATA[genetic mutations in breast cancer]]></category>
		<category><![CDATA[Liquid biopsy technology]]></category>
		<category><![CDATA[Non-invasive cancer diagnostics]]></category>
		<category><![CDATA[Precision oncology advancements]]></category>
		<guid isPermaLink="false">https://bioengineer.org/revolutionizing-breast-cancer-treatment-the-role-of-liquid-biopsy/</guid>

					<description><![CDATA[A groundbreaking study on circulating tumor DNA (ctDNA) testing for patients suffering from advanced breast cancer has emerged, yielding significant findings that may transform the landscape of oncology treatment. This research underscores the pivotal role of ctDNA as a non-invasive means to detect genetic mutations that can influence treatment decisions, thereby enhancing the precision of [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">236334</post-id>	</item>
	</channel>
</rss>
